Diagnosing Vesicoureteric Reflux in Children by Direct Isotope Cystography and Contrast Enhanced Voiding Ultrasonography
- Conditions
- VUR - Vesicoureteric Reflux
- Interventions
- Diagnostic Test: Contrast-enhanced voiding ultrasonography (CEVUS), Direct isotope cystography
- Registration Number
- NCT06138080
- Lead Sponsor
- Turku University Hospital
- Brief Summary
The purpose of this study is to examine the applicability of contrast enhanced voiding ultrasonography in diagnosing vesicoureteral reflux (VUR) in pediatric patients compared to direct isotope cystography. The aim of the study is to find a modality allowing the accurate diagnosis of VUR and the classification of the degree of VUR with the least possible harm from the examinations.
The investigators recruit 100 under 6 years old patients who have had at least 2 culture positive urinary tract infections. Exluding criteria are abnormal bladder function and posterior uretral valves. The investigators perform direct isotope cystography and contrast enhanced voiding urosonography during the same day to diagnose and grade VUR. The investigators use standardized volume and speed of bladder filling. The examinations are done by a radiologist and an isotope specialist and they are blinded to the result of the other examination.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 100
- under 6 years old patients who have had at least 2 culture positive urinary tract infections
- abnormal bladder function
- posterior uretral valves
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description VUR diagnostics Contrast-enhanced voiding ultrasonography (CEVUS), Direct isotope cystography -
- Primary Outcome Measures
Name Time Method Diagnostic accoracy of CEVUS in detecting vesicoureteral reflux 1 day The primary outcome measure of this study is the diagnostic accoracy of CEVUS in detecting vesicoureteral reflux compared to direct isotope cystography, expressed as the sensitivity and specificity of each method
- Secondary Outcome Measures
Name Time Method Incidence and severity of adverse effects associated with CEVUS 1 year The secondary outcome measure of this study is the incidence and severity of adverse effects associated with CEVUS as compared to direct isotope cystography.
Trial Locations
- Locations (1)
Turku University hospital
🇫🇮Turku, Finland